Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study

J Clin Psychopharmacol. 2014 Dec;34(6):749-51. doi: 10.1097/JCP.0000000000000222.

Authors

Beth L Murphy¹, Caitlin Ravichandran, Suzann M Babb, Bruce M Cohen

Affiliation

¹ Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA BMurphy5@partners.org Harvard Medical School Boston, MA and Laboratory for Psychiatric Biostatistics McLean Hospital Belmont, MA Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA.

PMID: 25310199
DOI: 10.1097/JCP.0000000000000222

No abstract available

Publication types

Controlled Clinical Trial
Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Bipolar Disorder / diagnosis
Bipolar Disorder / drug therapy*
Bipolar Disorder / epidemiology
Depressive Disorder / diagnosis
Depressive Disorder / drug therapy*
Depressive Disorder / epidemiology
Double-Blind Method
Humans
Middle Aged
Naltrexone / therapeutic use*
Narcotic Antagonists / therapeutic use*
Young Adult

Substances

Narcotic Antagonists
Naltrexone